81560 CPT® code: payer coverage and prior authorization27 of 27 payer prior-auth lists that name 81560 require prior authorization or set conditions: Humana, Molina Complete Care (Virginia), Molina Healthcare of Arizona, Molina Healthcare of California, Molina Healthcare of Idaho, Molina Healthcare of Illinois, Molina Healthcare of Iowa, Molina Healthcare of Michigan, Molina Healthcare of Mississippi, Molina Healthcare of Nevada, Molina Healthcare of New Mexico, Molina Healthcare of Ohio, Molina Healthcare of Texas, Passport by Molina Healthcare (Kentucky), Rocky Mountain Health Plans.
81560 appears in 10 coverage policies from Aetna, Anthem, Blue Cross & Blue Shield of Mississippi, Blue Cross & Blue Shield of Rhode Island, Blue Cross Blue Shield of Massachusetts, Blue Cross NC, BlueCross BlueShield of South Carolina, Cigna, Premera Blue Cross, Regence.
| Payer | Policy | Role in policy | Reviewed | Document |
|---|---|---|---|---|
| Aetna | Transplant Immune Cell Function Assays (0773) T-SPOT.CMV, gamma interferon response for measurement of the bioactivity of immunosuppressive medications in lung transplantation | not covered | Dec 23, 2025 | payer document |
| Anthem | Immune Cell Function Assay (LAB.00024) | unproven / investigational | Nov 6, 2025 | payer document |
| Blue Cross & Blue Shield of Mississippi | Immune Cell Function Assay | unproven / investigational | payer document | |
| Blue Cross & Blue Shield of Rhode Island | Immune Cell Function Assay | not covered | Feb 4, 2026 | payer document |
| Blue Cross Blue Shield of Massachusetts | Immune Cell Function Assay (182) | unproven / investigational | payer document | |
| Blue Cross NC | Immune Cell Function Assay AHS - G2098 | listed, no stance | Jan 1, 2026 | payer document |
| BlueCross BlueShield of South Carolina | Immune Cell Function Assay (CAM 322) | listed, no stance | Jan 1, 2026 | payer document |
| Cigna | Laboratory Testing Services (0604) | not covered | May 15, 2026 | payer document |
| Premera Blue Cross | Immune Cell Function Assay | listed, no stance | Oct 14, 2025 | payer document |
| Regence | Laboratory Tests for Organ Transplant Rejection (Laboratory 51) | listed, no stance | Jul 1, 2026 | payer document |
Prior authorization required or conditional in IN, MS.
From payers' published prior-auth lists, coverage policies and state Medicaid fee schedules, updated Oct 16, 2026. The role is what the policy's own code table or text says about the code. Not a guarantee of coverage or payment; verify with the payer. CPT® is a registered trademark of the American Medical Association.